Targeting tumor-associated macrophages as a novel strategy against breast cancer. - Wikidata - awgldk - TriplyDB

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

http://www.wikidata.org/entity/Q34803221

about

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion Functional significance of macrophages in pancreatic cancer biology Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities The importance of nerve microenvironment for schwannoma development.Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation Working hypothesis to redefine endothelial progenitor cells Nanoparticle Uptake: The Phagocyte Problem IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN Breast tumour stroma is a prognostic indicator and target for therapy.Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.Cytomegalovirus, Macrophages and Breast Cancer.Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Vaccines against human carcinomas: strategies to improve antitumor immune responses.Active immunotherapy induces antibody responses that target tumor angiogenesis.Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice.Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization.CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.Strategies for advancing cancer nanomedicine.The oncogenic potential of human cytomegalovirus and breast cancer.Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.Fluorescent nanoparticle imaging allows noninvasive evaluation of immune cell modulation in esophageal dysplasia.Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.Vaccines targeting the neovasculature of tumors Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.Para-inflammation mediates systemic DNA damage in response to tumor growth.

P2860

Q21245767-7AD22E9E-5C92-44F1-9092-9672B6FC82FF Q24321517-4057396D-A6C6-4A21-9544-627B06019D87 Q26786515-B273F63E-267E-48D3-A2F2-BE3B9D00F798 Q27011598-22C81E89-9381-4E32-8E71-08681533AC2F Q27321805-E3635FBE-491E-4E84-9D33-40FF0C299ACB Q27331013-2E429BED-1058-45F1-BB0B-C74B307C9C6D Q27678659-C77183AB-DE07-4B47-A894-F60830C7E58B Q28295515-DB221CF0-B388-4C20-9AF7-81A904CD8C94 Q28395287-8A527968-ED81-4ACA-8364-ABB1C171097A Q28535709-77838C39-0822-48F2-84F3-14A9A7EEDA38 Q28536347-65CE2C8D-ED39-4964-AEC6-AC21F5028E70 Q28743158-276E9681-D0C6-4D2D-ACA0-D40B819CA62C Q29619346-5404ED6E-7740-4C9C-B7F5-FD6E911A7E78 Q33555526-F28B1A98-8A01-4B08-823B-F0CFC97BF65B Q33634686-929ADE0D-A54A-4089-A5C4-6E6B1CBC81E8 Q33645055-C2C00D36-43E8-4E5D-887F-B4B806C71AF4 Q33654352-3F7994B7-F769-454E-824E-6390A6AC68E2 Q33734281-A4FDA8EC-CFB7-4EF1-B897-DC92616256F8 Q33772446-33137BDA-18CC-4F43-B5EC-1612F902D480 Q33814920-C4BB05D2-508F-42E6-ABC0-09C873AB474A Q33844796-4D723415-1C8D-47DB-AC79-FFEA903E1846 Q33882555-F9A48371-5018-42F8-BF56-40E401052D72 Q33905932-1219F984-E7B7-4473-B039-61D3545649C7 Q33995719-B794B3B8-F6AF-495E-B6EA-C3C43A61232C Q34081724-A62A6ECC-754F-461C-89A1-B2F01CA5DF49 Q34127426-DBBDB0A0-EBA7-4784-8912-E2D4029C7923 Q34154823-64D03413-10F4-45A3-86D8-8B4004260C77 Q34163579-0AE7447F-AB7E-487A-BA22-D71F291324CA Q34257800-85CFCE21-0E9E-495C-B302-2CBA33F81B7E Q34354547-4CB657A9-895E-41A8-85F0-D84A446BB1E1 Q34406206-C1136ED0-7374-4344-89A6-F494D7E49CED Q34541239-809BA9D1-8D9C-4261-8613-48025B2982E5 Q34546566-E4A4E706-32D2-429E-9305-D8C8CAF5E490 Q34575418-8C83CE76-FD81-4253-A733-31A408BFAA24 Q34626551-DF924ECC-ACDE-41FB-A193-AD0A4AAB0340 Q34631475-3B28DADA-DD25-4306-975C-2FCCF85970D9 Q34631566-018F5062-C480-4C62-BAE5-52B86C66B4FA Q34704905-8B917892-A4DB-495A-8EDA-4367493F1157 Q34759911-D3C459A5-AF5D-46AF-8271-3792BE3B155D Q34775501-F526CDD2-CF2C-48AE-B668-BE9D6B3F1BD8

P2860

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

http://www.wikidata.org/entity/Q34803221

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@ast

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@en

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@nl

type

label

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@ast

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@en

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@nl

prefLabel

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@ast

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@en

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@nl

P1433

Q34803221-91B0448D-0517-498D-9800-7C9A3A69B306

P1476

Q34803221-591FFEF2-4235-4BD7-A5E0-7FEE03CD99DB

P2093

Q34803221-193EA37F-74DD-48D1-B76B-F3993B0D0090

Q34803221-4D045D2E-415F-43BB-AF4A-382D82A174A7

Q34803221-6E570660-DA96-4CD1-8AA5-22B60A4EE9BB

Q34803221-96D33828-9145-4F62-BB00-962D13A73C27

Q34803221-B276A505-46BE-4DF6-AA2E-07C6A68FB2B4

Q34803221-C06193DC-9081-4B72-A6FB-51E9156FB14D

Q34803221-C1220B90-A6A4-48B6-81C7-070C829F0DF6

Q34803221-D58F1280-A88B-423B-9DD8-1810166BFE05

Q34803221-E164F364-A246-403D-8EBF-FB91653CDF29

Q34803221-EAB8FBC6-D16A-49C9-B99A-1564C3B401A3

P2860

Q34803221-009F1A60-0EE8-44C5-A494-0221A357E4BF

Q34803221-0248F1D2-EFAC-4102-96BF-7807CA9D8E3C

Q34803221-05BC38BB-EA38-431E-9DA7-2F56AF296F4A

Q34803221-09AAB012-EF64-4BC8-BF2E-04267AD6E643

Q34803221-10CFCA1C-352F-467E-A099-C1B96A8C270E

Q34803221-15EE490E-01DC-44E7-A264-A1F3EA265F86

Q34803221-1C3F5518-06CD-4DE8-B9ED-D5707371AE20

Q34803221-3662212C-372B-48A5-A323-B7DCD081458B

Q34803221-3B0C6793-D30C-4FA9-B4AB-0E17C5C498C0

Q34803221-3EABD147-D106-4FC4-972F-1EC28D322049

P304

Q34803221-51C405D1-9D94-4E44-B456-4A6677BF5F9C

P31

Q34803221-5BCDB482-3131-43C0-A90B-DA4D6E8B1DB9

P356

Q34803221-96D055FD-C564-4BF1-8274-063DF1A05C96

P407

Q34803221-80191EA8-948F-48E0-92BE-D38E95691F44

P433

Q34803221-C025C0F1-EABB-4D1D-98E6-3A3BC21E73FD

P478

Q34803221-6392CEB0-087F-437F-B538-77ABBC10021D

P577

Q34803221-1AEC6A39-F8EF-43F2-9D70-9B30FC74F3A4

P698

Q34803221-98B8839D-4E6C-4613-B247-A243D8661B91

P921

Q34803221-F1DFE5B5-4A3C-4061-85D1-F3242A8C353F

P932

Q34803221-6C1D4C11-3C93-47A0-A402-0F68C49CCD6F

P356

P1433

Journal of Clinical Investigation

P1476

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

@en

P2093

Carrie Dolman

http://www.w3.org/2001/XMLSchema#string

Charles Kaplan

http://www.w3.org/2001/XMLSchema#string

Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Dorothy Markowitz

http://www.w3.org/2001/XMLSchema#string

He Zhou

http://www.w3.org/2001/XMLSchema#string

Jörg Krueger

http://www.w3.org/2001/XMLSchema#string

Ralph A Reisfeld

http://www.w3.org/2001/XMLSchema#string

Rong Xiang

http://www.w3.org/2001/XMLSchema#string

Sung-Hyung Lee

http://www.w3.org/2001/XMLSchema#string

Wenyuan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase

Inflammation and cancer

M-1/M-2 macrophages and the Th1/Th2 paradigm

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Tumour-educated macrophages promote tumour progression and metastasis

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

P304

2132-2141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI27648

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16862213

http://www.w3.org/2001/XMLSchema#string

P921

P932

1513049

http://www.w3.org/2001/XMLSchema#string